Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S A Shevchik"'
Autor:
М. V. Budzinskaya, I. V. Gurova, I. V. Schegoleva, V. B. Loschenov, S. А. Shevchik, S. G. Kuzjmin, G. N. Vorogtsov
Publikováno v:
Biomedical Photonics, Vol 2, Iss 1, Pp 20-24 (2013)
Treatment outcomes in patients with age-related vascular degeneration due to formation of subretinal neovascular membrane (SNM) of two groups: photodynamic therapy (PDT) with Photosens alone (18 patients) and in combination with anti-VEGF therapy wit
Externí odkaz:
https://doaj.org/article/e453004d4128455e8793cb2ce80152fc
Publikováno v:
Quantum Electronics. 32:959-962
A laser-spectroscopy system for the fluorescent diagnostics and photodynamic therapy of pathologic eye-fundus changes combined with the use of the Photosens compound is developed. The system is tested on experimental animals (mice and rabbits).
Autor:
V G, Likhvantseva, O Iu, Merzliakova, M V, Vereshchagina, S A, Shevchik, V B, Loshchenov, S G, Kuz'min, G N, Vorozhtsov
Publikováno v:
Vestnik oftalmologii. 124(1)
The authors present the results of an experimental study of the pattern of distribution of laser radiation at a wavelength of 810 nm in the normal and Photosens-photosensitized eye tissues and analyze the distribution of a temperature at the sclera/c
Autor:
M V, Budzinskaia, S A, Shevchik, T N, Kiseleva, V B, Loshchenov, I V, Gurova, I V, Shchegoleva, S G, Kuz'min, G N, Vorozhtsov
Publikováno v:
Vestnik oftalmologii. 123(6)
The paper shows the capacity of fluorescence diagnosis (FD) in patients with subretinal neovascular membranes. Photosens was used as a photosensitizer (PS) (NIOPIK) in FD. The agent was intravenously injected in a dose of 0.05 mg/kg. To study the kin
Autor:
S E, Avetisov, M V, Budzinskaia, T N, Kiseleva, E E, Kazarian, I V, Gurova, T V, Smirnova, I V, Shchegoleva, V B, Loshchenov, S A, Shevchik, S G, Kuz'min, G N, Vorozhtsov
Publikováno v:
Vestnik oftalmologii. 123(6)
The purpose of the study was to assess the results of photodynamic therapy (PDT) for subretinal neovascular membranes (SNM) in age-related macular degeneration (ARMD), by using the Russian drug Photosens. According to the treatment performed, all the
Autor:
S E, Avetisov, M V, Budzinskaia, T N, Kiseleva, E E, Kazarian, I V, Gurova, T V, Smirnova, I V, Shcheglova, E A, Privivkova, V B, Loshchenov, S A, Shevchik, S G, Kuz'min, G N, Vorozhtsov
Publikováno v:
Vestnik oftalmologii. 123(6)
The efficiency of photodynamic therapy (PDT) versus drug therapy was evaluated in patients with subretinal neovascular membranes (SNM) in complicated myopia (CM). Photosens (aluminum phthalocyanine) was intravenously injected in a dose of 0.05 mg/kg.
Autor:
S E, Avetisov, M V, Budzinskaia, T N, Kiseleva, E E, Kazarian, I V, Gurova, V B, Loshchenov, S A, Shevchik, S G, Kuz'min, G N, Vorozhtsov
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (8)
The authors studied the effectiveness of photodynamic therapy (PDT) with Photosence, a Russian photosensitizer, in treatment of chorioid neovascularization (CNV) in cases of age-related macular degeneration (ARMD) and pathological myopia (PM). The su
Autor:
M V, Budzinskaia, V G, Likhvantseva, S A, Shevchik, V B, Loshchenov, S G, Kuz'min, G N, Vorozhtsov
Publikováno v:
Vestnik oftalmologii. 121(5)
Whether Photosense (PS) may be used in the fluorescence diagnosis (FD) of experimental epibulbar and choroid tumors is discussed. The fluorescent ability of Photosense in FD permits detection of advanced malignancies. The kinetics of concentration of
Autor:
S A, Shevchik, M V, Loshchenov, G A, Meerovich, M V, Budzinskaia, N A, Ermakova, S S, Kharnas, V B, Loshchenov
Publikováno v:
Vestnik oftalmologii. 121(5)
By having a high photodynamic effectiveness and an ability of fluorescence, a Photosense photosensibilizer provides a way of combining photodynamic therapy (PDT) and monitoring its control within a session, which enhances the efficiency of treatment
Autor:
S E, Avetisov, M V, Budzinskaia, V G, Likhvantseva, I V, Gurova, V B, Loshchenov, S A, Shevchik, S G, Kuz'min, G N, Vorozhtsov
Publikováno v:
Vestnik oftalmologii. 121(5)
The subretinal neovascular membrane (SNM) is a common complication of diseases, such as senile macular degeneration, myopia, pseudohistoplasmic syndrome, and many others. There is no algorithm of treatment for this pathology in today's ophthalmologic